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Introduction
Type of treatment and some risk factors in cancer 
patients reduce elements of the immune systems, such as 
neutrophils (Rasmy et al., 2016). Neutropenia can lead to 
developing serious infection and death. The appearance 
of fever during neutropenia is usually due to the presence 
of bacteria, fungi or viruses (Gustinetti and Mikulska, 
2016a). Febrile neutropenia (FN) is defined as a single 
oral temperature measurement ≥ 38.3°C or a sustained oral 
temperature ≥ 38°C for more than one hour when absolute 
neutrophil count (ANC) is less than 500 cell/ μL or the 
reduction of ANC to 500 cell/ μL over the subsequent 48 
hours (Freifeld et al., 2011; Meidani et al., 2013). 
In patients undergoing chemotherapy for solid tumors, 
febrile neutropenia represents 50% of deaths, and the 
administration of antibiotics reduces the mortality rate to 
10% (Boada Burutaran et al., 2015). In the last decades, 
some significance advances in the prevention and 
treatment of febrile neutropenia have led to a decline in the 
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death rate, but still it is considered as a serious problem. 
However, in patients with solid tumors and hematological 
malignancies, the mortality rates were estimated 5% and 
11%, respectively (Rasmy et al., 2016).
The pattern of bacterial pathogens causing infection 
in cancer patients with febrile neutropenia has changed 
over the past decades (Kanamaru and Tatsumi, 2004). 
Gram-negative bacteria were detected as the main 
microorganisms in FN in the 1970, but Gram-positive 
bacteria became the predominant microorganisms 
in the 1980 (Rasmy et al., 2016). The prevalence of 
Gram-negative bacteria increased during the last two 
decades in adult with FN while in pediatric patients, an 
increase in Gram-positive bacteria was observed (Meidani 
et al., 2013). In some countries in Asia, such as Malaysia 
and Pakistan, the same trend was reported. Lee et al., 
(2011) demonstrated that Gram-negative microorganisms 
were the predominant pathogens in Asia-Pacific region. 
Several studies in Iran were reported the Gram-negative 
bacteria as the most common pathogens (Nejad et 
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al., 2015), but Meidani et al., (2013) showed that the 
Gram-positive bacteria were more prevalent.
Differences in the microbial spectrum of different 
countries show that knowing the pathogens associated 
with FN in each area is important for better management 
of febrile neutropenia in patients suffering from cancer 
(Meidani et al., 2013). In addition, with increasing rate 
of antibiotic resistance, knowledge about antimicrobial 
susceptibility and resistance patterns of causative bacteria 
in each region is necessary. Antimicrobial resistance is 
a current major international public health concern. In 
the other hands, reports on the bacterial spectrum and 
antimicrobial resistance pattern of bacteria from patients 
with cancer and febrile neutropenia in Iran are inadequate. 
The aim of this study was to determine bacterial 
spectrum and antimicrobial resistance pattern in bacteria 




A total of 212 febrile neutropenic cancer patients were 
enrolled in this prospective study. The participants were 
randomly selected among the cancer patients referred to 
Shahid Sadoughi hospital in Yazd, Iran, between 2012 
and 2015. The inclusion criteria were cancer, fever ≥ 
38.3°C, neutropenia (ANC < 500 cell/ μl) and positive 
blood culture for bacteria. Patients who had received 
antibiotics before admission were excluded from the study. 
Study objectives and procedures were explained to the 
participants, and they signed a written informed consent 
form. The study was approved by the Ethics committee 
of Shahid Sadoughi University of Medical Sciences. 
Demographics and clinical characteristics of all study 
participants were collected using a questionnaire.
Isolation of bacteria and antimicrobial susceptibility 
testing
Blood samples were taken for white blood cell count 
and absolute neutrophil count (ANC). In addition, the 
blood cultures were performed in BACTEC Plus Aerobic 
(&Anaerobic)/ F medium (BD, USA). All bottles were 
incubated in the Bactec 9240 instrument (BD, USA) for five 
days according to the manufacturer’s recommendations. 
Positive blood culture bottles were removed from 
the instrument. The Gram stain was performed on 
bottles, and a portion of the blood-broth mixture was 
subcultured onto solid plate media based on the results 
of the Gram stain. Subsequent isolation and identification 
of the bacteria was performed using conventional 
diagnostic methods such as, catalase, oxidase, coagulase, 
bacitracin, optochin, and CAMP test for gram-positive 
microorganisms, and oxidase, catalase, and biochemical 
tests for gram-negative isolates. The susceptibilities of 
all isolates to 14 different antibiotics were determined 
using disk diffusion (Kirby-Bauer method (Hudzicki, 
2009)) according to Clinical and Laboratory Standards 
Institute (CLSI) guidelines (Wikler, 2009). Antimicrobial 
susceptibility tests were conducted on Mueller-Hinton 
agar medium using commercial antibiotic disks (Padtan 
Teb Co, Tehran, Iran). The antibiotic disks used in the 
current study were cefixime (5μg), cefotaxime (30μg), 
ceftriaxone (30μg), ceftazidime (30μg), ciprofloxacin 
(5μg), meropenem (10μg), imipenem (10μg), amikacin 
(30μg), co-trimoxazole (25μg), gentamicin (10μg), 
nitrofurantoin (300μg), clindamycin (2μg), vancomycin 
(30μg), cloxacillin (1μg). E. coli (ATCC 25922) and S. 
aureus (ATCC 29213) were used as the reference strain 
for the antibiotic susceptibility tests.
Statistical Analysis
Statistical analysis of data was performed using 
SPSS version 19.0 (IBM Corp., Armonk, NY, USA). 
A correlation between gender, age and resistance to 
antibiotics was assessed by Chi-square test. The antibiotic 
resistance between patients with solid cancer and 
hematologic malignancies compared by Student t test. 
A p-value of less than 0.05 was defined significant for 
all testes.
Results 
The study population comprised 212 cancer patients 
with febrile neutropenia (98 men and 114 women). The 
mean age of the patients was 43.5 ± 24.98 years old. Out 
of 212 participants, 62.3℅ (132/212) were suffering from 
hematologic malignancies, and 37.7℅ (80/212) had solid 
tumors. The most common isolated microorganisms from 
febrile neutropenia cancer patients were gram-negative 
bacteria (180/212: 84.9℅). Escherichia coli was the most 
frequently isolated pathogen (38.68 %), followed by 
Klebsiella (14.15℅) and Acinetobacter species (11.32℅). 
The Genus and species of isolated pathogens are shown 
in Table 1.
No significant correlation was observed between 
gender, age and resistance to antibiotics under study 
(p=0.08). Resistance to co-trimoxazole in isolates of 
patients with hematologic malignancies was more 
than those bacteria isolated from solid cancer patients 
(p=0.002). Other antibiotics had the same effect on 
microorganisms of patients with solid cancer and 
hematologic malignancies (p>0.05). Gram-negative 
bacteria were susceptible to ciprofloxacin with a response 
range of 53.7% to 100%. The majority of E.coli isolates 
Pathogens No (%)
Gram-negative bacteria 180 (84.9)
     Escherichia coli 82 (38.68)
     Klebsiella species 30 (14.15)
     Acinetobacter species 24 (11.32)
     Enterobacter species 22 (10.38)
     Pseudomonas species 14 (6.60)
     Proteus species 8 (3.77)
Gram-positive bacteria 32 (15.1)
     Stapylococcus aurous 14 (6.60)
     Stapylococcus epidermidis 18 (8.50)
Table 1. Bacterial Pathogens Isolated from Cancer 
Patients with Febrile Neutropenia
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febrile nutropenic cancer patients in Kerman, Iran 
was Gram-positive. Use of intravenous catheter and 
fluoroquinolone prophylactic treatment for neutropenic 
cancer patients was increased the rate of Gram-positive 
bacteria. In study of Meidani et al., (2013) conducted 
in Isfahan, the prevalence of Gram-positive strains 
(56.4℅) in blood culture of cancer patients was more than 
Gram-negative bacteria. In comparison with our study, 
this study was conducted on low sample size with only 
23 positive blood culture. 
In the present study, Escherichia coli was the most 
prevalent isolated Gram- negative bacteria (38.68℅). 
Furthermore, many previous studies have found similar 
finding. In those studies, the means of E.coli isolations 
from blood culture of cancer patients was 30.8℅ 
(Trecarichi and Tumbarello, 2014b). In contrast with 
other studies, frequency of Klebsiella isolates (14.15℅) 
in our study was more than rate of Pseudomonas 
(6.60℅). Pseudomonas aeruginosa was the second most 
common isolated bacteria in the majority of studies with 
a mean frequency of 18.8% (Trecarichi and Tumbarello, 
2014a). In the current study, species of Acinetobacter 
and Enterobacter were isolated from blood culture with 
a frequency of 11.32℅ and 10.38℅, respectively. In 
addition, Proteus was isolated from 8 patients (3.3℅), 
while this microorganism has been previously isolated 
infrequently from cancer patients (Baskaran et al., 
2007; Sirkhazi et al., 2014). The gram-positive bacteria 
were isolated from 15.1℅ of our study populations and 
Staphylococcus epidermidis was the most common isolate 
(8.50℅). This finding is consistent with the result of other 
studies in Iran that were reported S.epidermidis as the most 
frequently gram-positive bacteria in febrile nutropenic 
cancer patients (Meidani et al., 2013; Amini et al., 2014; 
Nejad et al., 2015; Rezaee et al., 2017). 
Determination of antimicrobial susceptibility profile 
of bacterial pathogens in febrile neutropenic patients 
can be useful in selecting the best antimicrobial agent 
were sensitive to ceftazidime (87.8℅) and were resistance 
to co-trimoxazole (15.8℅). Klebsiella isolates were 
100% susceptible to all third-generation cephalosporins, 
meropenem and imipenem. Isolates of S.aureus and 
S.epidermidis exhibited 100% in vitro sensitivity to 
cloxacillin. All S.epidermidis isolates were resistance 
to clindamycin. The antimicrobial resistance patterns 
of bacterial pathogens isolated in patients with febrile 
neutropenia are represented in Table 2. 
Discussion 
The present study is the first report of the microbial 
spectrum and antimicrobial susceptibility profile from 
febrile neutropenic cancer patients in Yazd, Iran. The 
result of this study from the blood cultures of cancer 
patients revealed that Gram-negative bacteria were the 
predominant causative pathogens of bacteremia in febrile 
neutropenia patients. This finding is similar to reports 
before 1986 that Gram-negative bacteria were the most 
common cause of bacteremia (Nejad et al., 2015). During 
the last decades, the pattern of bacterial infections in 
febrile neutropenic patients with cancer has considerably 
changed. Gram-positive strains became predominant 
from the mid-1980s to several years ago. However, more 
recently this trend has shifted again toward Gram-negative 
strains in some countries (Gustinetti and Mikulska, 
2016b). 
In this study, Gram-negative bacteria were detected in 
84.9℅ of patients. In previous studies from 2007 to 2013, 
the rate of Gram-negative bacteria in febrile neutropenic 
cancer patients was 24.7 to 73.9% (mean 48.7%) 
(Trecarichi and Tumbarello, 2014a). Generally, the result 
obtained from this study is similar to recent reports that 
demonstrated the reemergence of Gram-negative bacteria 
as a major cause of infection in cancer patients (Meidani 
et al., 2013). However, in contrast with our data, Nejad 
et al., (2015) reported that 66℅ isolated bacteria from 










S. aureus S. 
epidermidis
Antibiotic
Cefixime 48.8 100 0 0 0 0 100 ND
Cefotaxime 70.7 100 0 0 0 0 100 ND
Ceftriaxone 75.6 100 0 0 0 0 80 0
Ceftazidime 87.8 100 0 9.1 42.9 0 100 ND
Ciprofloxacin 53.7 100 100 63.6 57.1 100 80 ND
Meropenem 53.7 100 100 40.0 100 100 ND 0
Imipenem 63.4 100 100 45.5 42.9 100 20 ND
Amikacin 70.7 6.7 ND 100.0 ND ND 0 ND
Co-trimoxazole 15.8 26.7 ND 100.0 ND ND 80 ND
Gentamicin 75.0 28.6 ND 100.0 0.0 ND 100 ND
Nitrofurantoin 84.6 24.6 ND 100.0 0.0 ND ND ND
Clindamycin ND ND ND ND ND ND 100 0
Vancomycin ND ND ND ND ND ND 28.6 100
Cloxacillin ND ND ND ND ND ND 100 100
Table 2. Antibiotic Sensitivity of Pathogens Isolated from Febrile Neutropenic Cancer Patients
ND, not determined
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(Almaziny, 2014). E coli resistance to fluoroquinolones 
is a problem in many countries (Huang et al., 2011) and 
we also found this phenomenon in our results. In this 
study, the majority of E.coli isolates were susceptible to 
cephalosporins especially ceftazidime (87.8℅). Studies 
conducted between 2006 and 2013 have reported that 
more than 95% of the E. coli isolates were susceptible 
to carbapenems (Trecarichi and Tumbarello, 2014a), 
but in the present study, less than 65℅ of E.coli isolates 
were sensitive to carbapenems. In our study, Klebsiella 
isolates were highly sensitive (100℅) to cephalosporins 
and carbapenems. This finding is consistent with other 
studies that were reported susceptibility ranging from 90 
to 100℅ for carbapenems (Trecarichi and Tumbarello, 
2014a). We found that none of S.epidermidis isolates were 
susceptible to clindamycin while, all S. aurous isolates 
(100℅) showed sensitivity to it. Majority of S. aurous 
isolates were resistance to vancomycin. This finding is 
incompatible with study conducted in Iran by Meidani 
et al., (2013). However, sample size in their study was 
low; therefore, they might have been underestimated the 
resistance rate. Consistent with several studies, no case of 
resistance to vancomycin was detected in S.epidermidis 
isolates. In addition, all gram-positive isolates shown 
susceptibility to cloxacillin. (Kim et al., 2005; Nejad et 
al., 2015). 
In conclusion, infections due to the Gram-negative 
bacteria were predominant in cancer patients with febrile 
neutropenia, and the most common isolate was E.coli. The 
majority of bacterial isolates were resistance to various 
antibiotics. Judicious use of antibiotic therapy is necessary 
to prevent the emergence and spread of antibiotic-resistant 
Gram-negative bacteria.
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